Evaluation of a procaspase-3 activator with hydroxyurea or temozolomide against high-grade meningioma in cell culture and canine cancer patients is a research paper published in Neuro-Oncology (2021). On theSindex it has a DataRank of 0. It has been cited 8 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Cancer Institute
Grant: R01CA120439
National Cancer Institute
Grant: Z01-BC006161
Canine Health Foundation
Grant: 02321
National Institutes of Health
Grant: T32-GM136629
Intramural NIH HHS
Grant: Z01 BC006161
NIGMS NIH HHS
Grant: T32 GM136629
National Institutes of Health
Grant: 5T32GM136629-02
Training Program at the Chemistry Biology Interface
National Institutes of Health
Grant: 4R01CA120439-09
Small Molecule Activators of Procaspases as Anti-Cancer Agents
National Institutes of Health
Grant: 1Z01BC006161-19
DNA Topoisomerases as Target of Action of Anticancer Dru
U.S. Department of Health and Human Services
FWCI
0.71
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals